Similar but not the same: Differential diagnosis of HLH and sepsis

Critical Reviews in Oncology/Hematology

Volumn 114, Issue , 2017, Pages 1-12

  Machowicz, Rafał ^a   Janka, Gritta ^b   Wiktor Jedrzejczak, Wieslaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Hemophagocytic lymphohistiocytosis; Hemophagocytic syndrome; HLH; Hyperferritinemia; Inflammation; Macrophage activation syndrome; MAS; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; FERRITIN; FIBRINOGEN; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL;

ANEMIA; CYTOKINE STORM; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROPHAGOCYTOSIS; FEVER; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERBILIRUBINEMIA; HYPERFERRITINEMIA; HYPERTRANSAMINASEMIA; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; HYPOFIBRINOGENEMIA; JAUNDICE; LYMPHADENOPATHY; MACROPHAGE ACTIVATION SYNDROME; NEUTROPHIL COUNT; PANCYTOPENIA; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RASH; REVIEW; SEPSIS; SEPTIC SHOCK; SPLENOMEGALY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; SEPSIS;

EID: 85018790991     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2017.03.023     Document Type: Review

References (120)

1. Allen, C.E., Yu, X., Kozinetz, C.A., McClain, K.L., Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 50 (2008), 1227–1235, 10.1002/pbc.21423.
2. Annane, D., Corticosteroids for severe sepsis: an evidence-based guide for physicians. Ann. Intensive Care, 1, 2011, 7, 10.1186/2110-5820-1-7.
3. Aricò, M., Janka, G., Fischer, A., Henter, J.I., Blanche, S., Elinder, G., Martinetti, M., Rusca, M.P., Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 10 (1996), 197–203.
4. Arismendi-Morillo, G.J., Briceño-García, A.E., Romero-Amaro, Z.R., Fernández-Abreu, M.C., Girón-Piña, H.E., Acute non-specific splenitis as indicator of systemic infection. Assessment of 71 autopsy cases. Invest. Clin. 45 (2004), 131–135.
5. Audemard-Verger, A., Descloux, E., Ponard, D., Deroux, A., Fantin, B., Fieschi, C., John, M., Bouldouyre, A., Karkowsi, L., Moulis, G., Auvinet, H., Valla, F., Lechiche, C., Davido, B., Martinot, M., Biron, C., Lucht, F., Asseray, N., Froissart, A., Buzelé, R., Perlat, A., Boutboul, D., Fremeaux-Bacchi, V., Isnard, S., Bienvenu, B., Infections revealing complement deficiency in adults: a French nationwide study enrolling 41 patients. Medicine (Baltimore), 95, 2016, e3548, 10.1097/MD.0000000000003548.
6. Aulagnon, F., Lapidus, N., Canet, E., Galicier, L., Boutboul, D., Peraldi, M.N., Reuter, D., Bernard, R., Schlemmer, B., Azoulay, E., Zafrani, L., Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am. J. Kidney Dis. 65 (2015), 851–859, 10.1053/j.ajkd.2014.10.012.
7. Bay, A., Oner, A.F., Kose, D., Dogan, M., Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation. Blood Coagul. Fibrinolysis 17 (2006), 569–573, 10.1097/01.mbc.0000245304.95138.cf.
8. Berbée, J.F.P., van der Hoogt, C.C., de Haas, C.J.C., van Kessel, K.P.M., Dallinga-Thie, G.M., Romijn, J.a., Havekes, L.M., van Leeuwen, H.J., Rensen, P.C.N., Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis. Intensive Care Med. 34 (2008), 907–911, 10.1007/s00134-008-1006-y.
9. Bernard, G.R., Francois, B., Mira, J.-P., Vincent, J.-L., Dellinger, R.P., Russell, J.A., Larosa, S.P., Laterre, P.-F., Levy, M.M., Dankner, W., Schmitt, N., Lindemann, J., Wittebole, X., Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study. Crit. Care Med. 42 (2014), 504–511, 10.1097/CCM.0000000000000043.
10. Besset, S., Schnell, D., Azoulay, É., Hemophagocytic lymphohistiocytosis mimicking septic shock. Chest, 2012, 10.1378/chest.11-2717.
11. Beutel, K., Gross-Wieltsch, U., Wiesel, T., Zur Stadt, U., Janka, G., Wagner, H.J., Infection of T lymphocytes in Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr. Blood Cancer 53 (2009), 184–190, 10.1002/pbc.22037.
12. Bien, E., Balcerska, A., Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers 13 (2008), 1–26, 10.1080/13547500701674063.
13. Bryceson, Y.T., Pende, D., Maul-Pavicic, A., Gilmour, K.C., Ufheil, H., Vraetz, T., Chiang, S.C., Marcenaro, S., Meazza, R., Bondzio, I., Walshe, D., Janka, G., Lehmberg, K., Beutel, K., zur Stadt, U., Binder, N., Arico, M., Moretta, L., Henter, J.-I., Ehl, S., A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood 119 (2012), 2754–2763, 10.1182/blood-2011-08-374199.
14. Buyse, S., Teixeira, L., Galicier, L., Mariotte, E., Lemiale, V., Seguin, A., Bertheau, P., Canet, E., de Labarthe, A., Darmon, M., Rybojad, M., Schlemmer, B., Azoulay, E., Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med. 36 (2010), 1695–1702, 10.1007/s00134-010-1936-z.
15. Castillo, L., Carcillo, J., Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr. Crit. Care Med. 10 (2009), 387–392, 10.1097/PCC.0b013e3181a1ae08.
16. Cetica, V., Sieni, E., Pende, D., Danesino, C., De Fusco, C., Locatelli, F., Micalizzi, C., Putti, M.C., Biondi, A., Fagioli, F., Moretta, L., Griffiths, G.M., Luzzatto, L., Aricò, M., Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry. J. Allergy Clin. Immunol., 137, 2016, 10.1016/j.jaci.2015.06.048 188.e4-1880196.e.e4.
17. Chellapandian, D., Das, R., Zelley, K., Wiener, S.J., Zhao, H., Teachey, D.T., Nichols, K.E., Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br. J. Haematol. 162 (2013), 376–382, 10.1111/bjh.12386.
18. Cho, E., Lee, J.H., Lim, H.J., Oh, S.W., Jo, S.K., Cho, W.Y., Kim, H.K., Lee, S.Y., Soluble CD25 is increased in patients with sepsis-induced acute kidney injury. Nephrology 19 (2014), 318–324, 10.1111/nep.12230.
19. Chong, J., Jones, P., Spelman, D., Leder, K., Cheng, A.C., Overwhelming post-splenectomy sepsis in patients with asplenia and hyposplenia: a retrospective cohort study. Epidemiol. Infect. 145 (2017), 397–400, 10.1017/S0950268816002405.
20. Chung, L.P., Waterer, G.W., Genetic predisposition to respiratory infection and sepsis. Crit. Rev. Clin. Lab. Sci. 48 (2011), 250–268, 10.3109/10408363.2011.641517.
21. Colafrancesco, S., Priori, R., Alessandri, C., Astorri, E., Perricone, C., Blank, M., Agmon-Levin, N., Shoenfeld, Y., Valesini, G., sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia. Immunol. Res. 60 (2014), 177–183, 10.1007/s12026-014-8563-7.
22. Colobran, R., Álvarez de la Campa, E., Soler-Palacín, P., Martín-Nalda, A., Pujol-Borrell, R., de la Cruz, X., Martínez-Gallo, M., Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome. Clin. Immunol. 163 (2016), 60–65, 10.1016/j.clim.2015.12.014.
23. Créput, C., Galicier, L., Buyse, S., Azoulay, E., Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 34 (2008), 1177–1187, 10.1007/s00134-008-1111-y.
24. Darcy, C.J., Davis, J.S., Woodberry, T., McNeil, Y.R., Stephens, D.P., Yeo, T.W., Anstey, N.M., An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function. PLoS ONE, 6, 2011, e21185, 10.1371/journal.pone.0021185.
25. Darveau, M., Denault, A.Y., Blais, N., Notebaert, E., Bench-to-bedside review: iron metabolism in critically ill patients. Crit. Care 8 (2004), 356–362, 10.1186/cc2862.
26. de Oliveira-Junior, E.B., Zurro, N.B., Prando, C., Cabral-Marques, O., Pereira, P.V.S., Schimke, L.-F., Klaver, S., Buzolin, M., Blancas-Galicia, L., Santos-Argumedo, L., Pietropaolo-Cienfuegos, D.R., Espinosa-Rosales, F., King, A., Sorensen, R., Porras, O., Roxo-Junior, P., Forte, W.C.N., Orellana, J.C., Lozano, A., Galicchio, M., Regairaz, L., Grumach, A.S., Costa-Carvalho, B.T., Bustamante, J., Bezrodnik, L., Oleastro, M., Danielian, S., Condino-Neto, A., Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin American patients: first report from the LASID registry. Pediatr. Blood Cancer 62 (2015), 2101–2107, 10.1002/pbc.25674.
27. Fardet, L., Lambotte, O., Meynard, J.-L., Kamouh, W., Galicier, L., Marzac, C., de Labarthe, A., Cabane, J., Lebbe, C., Coppo, P., Molina, J.-M., Martinez, V., Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis. AIDS 24 (2010), 1299–1306, 10.1097/QAD.0b013e328339e55b.
28. Feig, J.A., Cina, S.J., Evaluation of characteristics associated with acute splenitis (septic spleen) as markers of systemic infection. Arch. Pathol. Lab. Med. 125 (2001), 888–891, 10.1043/0003-9985(2001)125<0888:EOCAWA>2.0.CO;2.
29. Filipovich, A.H., Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am. Soc. Hematol. Educ. Program, 2009, 127–131, 10.1182/asheducation-2009.1.127.
30. Fitrolaki, D.-M., Dimitriou, H., Kalmanti, M., Briassoulis, G., CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children. BMC Pediatr., 13, 2013, 31, 10.1186/1471-2431-13-31.
31. François, B., Trimoreau, F., Vignon, P., Fixe, P., Praloran, V., Gastinne, H., Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am. J. Med. 103 (1997), 114–120.
32. Funke, A., Berner, R., Traichel, B., Schmeisser, D., Leititis, J.U., Niemeyer, C.M., Frequency, natural course, and outcome of neonatal neutropenia. Pediatrics 106 (2000), 45–51.
33. Garcia, P.C.R., Longhi, F., Branco, R.G., Piva, J.P., Lacks, D., Tasker, R.C., Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr. 96 (2007), 1829–1831, 10.1111/j.1651-2227.2007.00564.x.
34. Georgeson, G.D., Szony, B.J., Streitman, K., Kovács, A., Kovács, L., László, A., Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections. Eur. J. Pediatr. 160 (2001), 478–482.
35. Goel, S., Polski, J.M., Imran, H., Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Ann. Clin. Lab. Sci. 42 (2012), 21–25.
36. Gonano, C., Sitzwohl, C., Meitner, E., Weinstabl, C., Kettner, S.C., Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit. Care, 10, 2006, R160, 10.1186/cc5098.
37. Grion, C.M.C., Cardoso, L.T.Q., Perazolo, T.F., Garcia, A.S., Barbosa, D.S., Morimoto, H.K., Matsuo, T., Carrilho, A.J.F., Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients. Eur. J. Clin. Invest. 40 (2010), 330–338, 10.1111/j.1365-2362.2010.02269.x.
38. Gupta, A., Tyrrell, P., Valani, R., The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 51 (2008), 402–404, 10.1002/pbc.21564.
39. Gupta, A., Weitzman, S., Abdelhaleem, M., The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 50 (2008), 192–194, 10.1002/pbc.21441.
40. Gürgey, A., Göğüş, S., Ozyürek, E., Aslan, D., Gümrük, F., Cetin, M., Yüce, A., Ceyhan, M., Seçmeer, G., Yetgin, S., Hiçsönmez, G., Primary hemophagocytic lymphohistiocytosis in Turkish children. Pediatr. Hematol. Oncol. 20 (2003), 367–371, 10.1080/08880010390203891.
41. Hasday, J.D., Garrison, A., Antipyretic therapy in patients with sepsis. Clin. Infect. Dis. 31:Suppl 5 (2000), S234–S241, 10.1086/317514.
42. Henter, J.-I., Horne, A., Aricó, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., Janka, G., HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48 (2007), 124–131, 10.1002/pbc.21039.
43. Ho, C., Yao, X., Tian, L., Li, F.-Y., Podoltsev, N., Xu, M.L., Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am. J. Clin. Pathol. 141 (2014), 62–71, 10.1309/AJCPMD5TJEFOOVBW.
44. Horne, A., Trottestam, H., Aricò, M., Egeler, R.M., Filipovich, A.H., Gadner, H., Imashuku, S., Ladisch, S., Webb, D., Janka, G., Henter, J.-I., Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br. J. Haematol. 140 (2008), 327–335, 10.1111/j.1365-2141.2007.06922.x.
45. Imashuku, S., Treatment of Epstein–Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010. J. Pediatr. Hematol. Oncol. 33 (2011), 35–39, 10.1097/MPH.0b013e3181f84a52.
46. Imashuku, S., Hibi, S., Sako, M., Ishida, Y., Mugishima, H., Chen, J., Tsunematsu, Y., Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 86 (1995), 4706–4707.
47. Imashuku, S., Kuriyama, K., Teramura, T., Ishii, E., Kinugawa, N., Kato, M., Sako, M., Hibi, S., Requirement for etoposide in the treatment of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. J. Clin. Oncol. 19 (2001), 2665–2673.
48. Ishikawa, K., Tanaka, H., Nakamori, Y., Hosotsubo, H., Ogura, H., Nishino, M., Shimazu, T., Sugimoto, H., Difference in the responses after administration of granulocyte colony-stimulating factor in septic patients with relative neutropenia. J. Trauma 48 (2000), 814–824.
49. Janka, G.E., Familial and acquired hemophagocytic lymphohistiocytosis. Eur. J. Pediatr. 166 (2007), 95–109, 10.1007/s00431-006-0258-1.
50. Janka, G.E., Hemophagocytic syndromes. Blood Rev. 21 (2007), 245–253, 10.1016/j.blre.2007.05.001.
51. Janka, G.E., Schneider, E.M., Modern management of children with haemophagocytic lymphohistiocytosis. Br. J. Haematol. 124 (2004), 4–14.
52. Jędrzejczak, W.W., Limfohistiocytoza hemofagocytarna—rzadko rozpoznawany uleczalny stan bezpośredniego zagrozenia zycia występujący równiez u dorosłych. Acta Haematol. Pol. 39 (2008), 515–526.
53. Jordan, M.B., Allen, C.E., Weitzman, S., Filipovich, A.H., McClain, K.L., How I treat hemophagocytic lymphohistiocytosis. Blood 118 (2011), 4041–4052, 10.1182/blood-2011-03-278127.
54. Kanevskiy, L.M., Telford, W.G., Sapozhnikov, A.M., Kovalenko, E.I., Lipopolysaccharide induces IFN-γ production in human NK cells. Front. Immunol., 4, 2013, 11, 10.3389/fimmu.2013.00011.
55. Karvunidis, T., Chvojka, J., Lysak, D., Sykora, R., Krouzecky, A., Radej, J., Novak, I., Matejovic, M., Septic shock and chemotherapy-induced cytopenia: effects on microcirculation. Intensive Care Med. 38 (2012), 1336–1344, 10.1007/s00134-012-2582-4.
56. Kim, J., Yoo, S.W., Kang, S.-R., Bom, H.-S., Song, H.-C., Min, J.-J., Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Ann. Hematol., 2013, 661–667, 10.1007/s00277-013-1906-y.
57. Kinasewitz, G.T., Zein, J.G., Lee, G.L., Nazir, S., Taylor, A.F.B., Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis. Crit. Care Med. 33 (2005), 2214–2221, 10.1097/01.CCM.0000181296.53204.DE.
58. Koh, K.-N., Im, H.J., Chung, N.-G., Cho, B., Kang, H.J., Shin, H.Y., Lyu, C.J., Yoo, K.H., Koo, H.H., Kim, H.-J., Baek, H.J., Kook, H., Yoon, H.S., Lim, Y.T., Kim, H.S., Ryu, K.H., Seo, J.J., Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur. J. Haematol. 94 (2015), 51–59, 10.1111/ejh.12399.
59. Komp, D.M., McNamara, J., Buckley, P., Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 73 (1989), 2128–2132.
60. Lehmberg, K., McClain, K.L., Janka, G.E., Allen, C.E., Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer, 2014, 2–4, 10.1002/pbc.25058.
61. Lehmberg, K., Pink, I., Eulenburg, C., Beutel, K., Maul-Pavicic, A., Janka, G., Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. J. Pediatr. 162 (2013), 1245–1251, 10.1016/j.jpeds.2012.11.081.
62. Lekkou, A., Mouzaki, A., Siagris, D., Ravani, I., Gogos, C.A., Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J. Crit. Care 29 (2014), 723–727, 10.1016/j.jcrc.2014.04.018.
63. Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S.M., Vincent, J.-L., Ramsay, G., 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit. Care Med. 31 (2003), 1250–1256, 10.1097/01.CCM.0000050454.01978.3B.
64. Li, F., Li, P., Zhang, R., Yang, G., Ji, D., Huang, X., Xu, Q., Wei, Y., Rao, J., Huang, R., Chen, G., Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Med. Oncol., 2014, 31, 10.1007/s12032-014-0902-y.
65. Li, J., Wang, Q., Zheng, W., Ma, J., Zhang, W., Wang, W., Tian, X., Hemophagocytic lymphohistiocytosis. Medicine (Baltimore) 93 (2014), 100–105, 10.1097/MD.0000000000000022.
66. Li, F., Yang, Y., Jin, F., Dehoedt, C., Rao, J., Zhou, Y., Li, P., Yang, G., Wang, M., Zhang, R., Yang, Y., Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J. Rare Dis., 10, 2015, 20, 10.1186/s13023-015-0224-y.
67. Lin, T.F., Ferlic-Stark, L.L., Allen, C.E., Kozinetz, C.A., McClain, K.L., Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr. Blood Cancer 56 (2011), 154–155, 10.1002/pbc.22774.
68. Lissalde-Lavigne, G., Combescure, C., Muller, L., Bengler, C., Raillard, A., Lefrant, J.-Y., Gris, J.-C., Simple coagulation tests improve survival prediction in patients with septic shock. J. Thromb. Haemost. 6 (2008), 645–653, 10.1111/j.1538-7836.2008.02895.x.
69. Llewelyn, M.J., Berger, M., Gregory, M., Ramaiah, R., Taylor, A.L., Curdt, I., Lajaunias, F., Graf, R., Blincko, S.J., Drage, S., Cohen, J., Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit. Care, 17, 2013, R60, 10.1186/cc12588.
70. Machaczka, M., Sydor, W., Rucińska, M., Szostek, M., Musiał, J., Autoimmune-associated hemophagocytic syndrome/macrophage activation syndrome. Fang-Ping, Huang, (eds.) Autoimmune Disorders – Current Concepts and Advances from Bedside to Mechanistic Insights, 2011, InTech, Rijeka, Croatia, 79–103.
71. Machaczka, M., Vaktnäs, J., Klimkowska, M., Hägglund, H., Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk. Lymphoma 52 (2011), 613–619, 10.3109/10428194.2010.551153.
72. Machowicz, R., Kröger, N., Krieger, T., Zborowska, H., Rejowski, S., Górka, M., Wiktor-Jedrzejczak, W., Hyperferritinemia in adult HLH: the best what we have, so far. Blood [e-Letter], 2015 http://www.bloodjournal.org/content/125/10/1548.e-letter.
73. Machowicz, R., Janka, G., Wiktor-Jedrzejczak, W., Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis). Crit. Care, 20, 2016, 215, 10.1186/s13054-016-1369-3.
74. Martin, C.M., Priestap, F., Fisher, H., Fowler, R.A., Heyland, D.K., Keenan, S.P., Longo, C.J., Morrison, T., Bentley, D., Antman, N., A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit. Care Med. 37 (2009), 81–88, 10.1097/CCM.0b013e31819285f0.
75. Mauhin, W., Habarou, F., Gobin, S., Servais, A., Brassier, A., Grisel, C., Roda, C., Pinto, G., Moshous, D., Ghalim, F., Krug, P., Deltour, N., Pontoizeau, C., Dubois, S., Assoun, M., Galmiche, L., Bonnefont, J.-P., Ottolenghi, C., de Blic, J., Arnoux, J.-B., de Lonlay, P., Update on lysinuric protein intolerance, a multi-faceted disease retrospective cohort analysis from birth to adulthood. Orphanet J. Rare Dis., 12, 2017, 3, 10.1186/s13023-016-0550-8.
76. Mavrommatis, A.C., Theodoridis, T., Orfanidou, A., Roussos, C., Christopoulou-Kokkinou, V., Zakynthinos, S., Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit. Care Med. 28 (2000), 451–457.
77. Meeths, M., Horne, A., Sabel, M., Bryceson, Y.T., Henter, J.-I., Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden. Pediatr. Blood Cancer 14 (2014), 346–352, 10.1002/pbc.25308.
78. Ménasché, G., Feldmann, J., Fischer, A., de Saint Basile, G., Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol. Rev. 203 (2005), 165–179, 10.1111/j.0105-2896.2005.00224.x.
79. Møller, H.J., Moestrup, S.K., Weis, N., Wejse, C., Nielsen, H., Pedersen, S.S., Attermann, J., Nexø, E., Kronborg, G., Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit. Care Med. 34 (2006), 2561–2566, 10.1097/01.CCM.0000239120.32490.AB.
80. Nair, V., Das, S., Sharma, A., Sharma, S., Sharma, P., Ray, S., Bhattacharya, S., A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment. Postgrad. Med. J. 89 (2013), 185–192, 10.1136/postgradmedj-2012-130955.
81. Niece, J.A., Rogers, Z.R., Ahmad, N., Langevin, A.-M., McClain, K.L., Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race. Pediatr. Blood Cancer 54 (2010), 424–428, 10.1002/pbc.22359.
82. Otrock, Z.K., Eby, C.S., Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am. J. Hematol. 90 (2015), 220–224, 10.1002/ajh.23911.
83. Ozen, S., Dai, A., Coskun, E., Oztuzcu, S., Ergun, S., Aktekin, E., Yavuz, S., Bay, A., Importance of Hyperbilirubinemia in Differentiation of Primary and Secondary Hemophagocytic Lymphohistiocytosis in Pediatric Cases. 2014, 10.4084/MJHID.2014.067.
84. Palazzi, D.L., McClain, K.L., Kaplan, S.L., Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin. Infect. Dis. 36 (2003), 306–312, 10.1086/345903.
85. Parikh, S.A., Kapoor, P., Letendre, L., Kumar, S., Wolanskyj, A.P., Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin. Proc., 2014, 1–9, 10.1016/j.mayocp.2013.12.012.
86. Park, H.-S., Kim, D.-Y., Lee, J.-H., Lee, J.-H., Kim, S.-D., Park, Y.-H., Lee, J.S., Kim, B.Y., Jeon, M., Kang, Y.-A., Lee, Y.-S., Seol, M., Lee, Y.-J., Lim, Y.-S., Jang, S., Park, C.-J., Chi, H.-S., Lee, K.-H., Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. Ann. Hematol. 91 (2012), 897–904, 10.1007/s00277-011-1380-3.
87. Park, H.-J., Ha, Y.-J., Pyo, J.-Y., Park, Y.-B., Lee, S.-K., Lee, S.-W., Delta neutrophil index as an early marker for differential diagnosis of adult-onset still's disease and sepsis. Yonsei Med. J. 55 (2014), 753–759, 10.3349/ymj.2014.55.3.753.
88. Peres Bota, D., Lopes Ferreira, F., Mélot, C., Vincent, J.L., Body temperature alterations in the critically ill. Intensive Care Med. 30 (2004), 811–816, 10.1007/s00134-004-2166-z.
89. Piagnerelli, M., Cotton, F., Herpain, A., Rapotec, A., Chatti, R., Gulbis, B., Vincent, J.-L., n.d. Time course of iron metabolism in critically ill patients. Acta Clin. Belg. 68, 22-7.
90. Prendki, V., Stirnemann, J., Lemoine, M., Lohez, M., Aras, N., Ganne-Carrié, N., Larroche, C., Roulot, D., Tengher-Barna, I., Fain, O., Ziol, M., Prevalence and clinical significance of Küpffer cell hyperplasia with hemophagocytosis in liver biopsies. Am. J. Surg. Pathol. 35 (2011), 337–345, 10.1097/PAS.0b013e318209c681.
91. Presneill, J.J., A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am. J. Respir. Crit. Care Med. 166 (2002), 138–143, 10.1164/rccm.2009005.
92. Put, K., Avau, A., Brisse, E., Mitera, T., Put, S., Proost, P., Bader-Meunier, B., Westhovens, R., Van den Eynde, B.J., Orabona, C., Fallarino, F., De Somer, L., Tousseyn, T., Quartier, P., Wouters, C., Matthys, P., Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ. Rheumatology (Oxford) 54 (2015), 1507–1517, 10.1093/rheumatology/keu524.
93. Ramachandran, B., Balasubramanian, S., Abhishek, N., Ravikumar, K.G., Ramanan, A.V., Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr. 48 (2011), 31–35.
94. Raschke, R.A., Garcia-Orr, R., Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest 140 (2011), 933–938, 10.1378/chest.11-0619.
95. Risma, K., Jordan, M.B., Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr. Opin. Pediatr. 24 (2012), 9–15, 10.1097/MOP.0b013e32834ec9c1.
96. Schram, A.M., Campigotto, F., Mullally, A., Fogerty, A., Massarotti, E., Neuberg, D., Berliner, N., Marked hyperferritinemia does not predict for HLH in the adult population. Blood 125 (2015), 1548–1552, 10.1182/blood-2014-10-602607.
97. Schram, A.M., Comstock, P., Campo, M., Gorovets, D., Mullally, A., Bodio, K., Arnason, J., Berliner, N., Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. Br. J. Haematol. 172 (2016), 412–419, 10.1111/bjh.13837.
98. Seo, J.J., Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: recent advances and controversies. Blood Res. 50 (2015), 131–139, 10.5045/br.2015.50.3.131.
99. Shabbir, M., Lucas, J., Lazarchick, J., Shirai, K., Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol. Oncol. 29 (2011), 100–106, 10.1002/hon.960.
100. Shimizu, M., Yokoyama, T., Yamada, K., Kaneda, H., Wada, H., Wada, T., Toma, T., Ohta, K., Kasahara, Y., Yachie, A., Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology 49 (2010), 1645–1653, 10.1093/rheumatology/keq133.
101. Spada, P.L., Rossi, C., Alimonti, A., Bocca, B., Cozza, V., Ricerca, B.M., Bocci, M.G., Vulpio, C., De Sole, P., Ferritin iron content in haemodialysis patients: comparison with septic and hemochromatosis patients. Clin. Biochem. 41 (2008), 997–1001, 10.1016/j.clinbiochem.2008.05.003.
102. Strauss, R., Neureiter, D., Westenburger, B., Wehler, M., Kirchner, T., Hahn, E.G., Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients—a postmortem clinicopathologic analysis. Crit. Care Med. 32 (2004), 1316–1321, 10.1097/01.CCM.0000127779.24232.15.
103. Tothova, Z., Berliner, N., Hemophagocytic syndrome and critical illness: new insights into diagnosis and management. J. Intensive Care Med. 30 (2015), 401–412, 10.1177/0885066613517076.
104. Trottestam, H., Horne, A., Aricò, M., Egeler, R.M., Filipovich, A.H., Gadner, H., Imashuku, S., Ladisch, S., Webb, D., Janka, G., Henter, J., Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118 (2011), 4577–4584, 10.1182/blood-2011-06-356261.
105. Tseng, Y.-T., Sheng, W.-H., Lin, B.-H., Lin, C.-W., Wang, J.-T., Chen, Y.-C., Chang, S.-C., Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J. Microbiol. Immunol. Infect. 44 (2011), 191–197, 10.1016/j.jmii.2011.01.027.
106. Tsuji, T., Hirano, T., Yamasaki, H., Tsuji, M., Tsuda, H., A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann. Hematol. 93 (2014), 821–826, 10.1007/s00277-013-1925-8.
107. van Leeuwen, H.J., Heezius, E.C.J.M., Dallinga, G.M., van Strijp, J.A.G., Verhoef, J., van Kessel, K.P.M., Lipoprotein metabolism in patients with severe sepsis. Crit. Care Med. 31 (2003), 1359–1366, 10.1097/01.CCM.0000059724.08290.51.
108. Vedrine, C., Caraion, C., Lambert, C., Genin, C., Cytometric bead assay of cytokines in sepsis: a clinical evaluation. Cytometry B. Clin. Cytom. 60 (2004), 14–22, 10.1002/cyto.b.20012.
109. Venkata, C., Kashyap, R., Farmer, J.C., Afessa, B., Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. J. Intensive Care, 1, 2013, 9, 10.1186/2052-0492-1-9.
110. Vincent, J.L., Baron, J.-F., Reinhart, K., Gattinoni, L., Thijs, L., Webb, A., Meier-Hellmann, A., Nollet, G., Peres-Bota, D., Anemia and blood transfusion in critically ill patients. JAMA 288 (2002), 1499–1507.
111. von Muller, L., Klemm, A., Durmus, N., Weiss, M., Suger-Wiedeck, H., Schneider, M., Hampl, W., Mertens, T., Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J. Infect. Dis. 196 (2007), 1288–1295, 10.1086/522429.
112. Wang, Y., Wang, Z., Zhang, J., Wei, Q., Tang, R., Qi, J., Li, L., Ye, L., Wang, J., Ye, L., Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood. PLoS ONE, 2014, 9, 10.1371/journal.pone.0107386.
113. Wang, Y., Huang, W., Hu, L., Cen, X., Li, L., Wang, J., Shen, J., Wei, N., Wang, Z., Multi-center study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood, 2015, 1–23, 10.1182/blood-2015-05-644914.
114. Weitzman, S., Approach to hemophagocytic syndromes. Hematology Am. Soc. Hematol. Educ. Program 2011 (2011), 178–183, 10.1182/asheducation-2011.1.178.
115. Xu, X.J., Tang, Y.M., Song, H., Yang, S.L., Xu, W.Q., Zhao, N., Shi, S.W., Shen, H.P., Mao, J.Q., Zhang, L.Y., Pan, B.H., Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J. Pediatr. 160 (2012), 984–990, 10.1016/j.jpeds.2011.11.046 e1.
116. Yasumi, T., Hori, M., Hiejima, E., Shibata, H., Izawa, K., Oda, H., Yoshioka, K., Nakagawa, K., Kawai, T., Nishikomori, R., Ohara, O., Heike, T., Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis. Br. J. Haematol., 2015 n/a-n/a, doi:10.1111/bjh.13461.
117. Yu, J.-T., Wang, C.-Y., Yang, Y., Wang, R.-C., Chang, K.-H., Hwang, W.-L., Teng, C.-L.J., Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann. Hematol. 92 (2013), 1529–1536, 10.1007/s00277-013-1784-3.
118. Zhang, K., Jordan, M.B., Marsh, R.A., Johnson, J.A., Kissell, D., Meller, J., Villanueva, J., Risma, K.A., Wei, Q., Klein, P.S., Filipovich, A.H., Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 118 (2011), 5794–5798, 10.1182/blood-2011-07-370148.
119. Zimmerman, J.L., Use of blood products in sepsis: an evidence-based review. Crit. Care Med. 32 (2004), S542–S547, 10.1097/01.CCM.0000145906.63859.1A.
120. Zoller, E.E., Lykens, J.E., Terrell, C.E., Aliberti, J., Filipovich, A.H., Henson, P.M., Jordan, M.B., Hemophagocytosis causes a consumptive anemia of inflammation. J. Exp. Med. 208 (2011), 1203–1214, 10.1084/jem.20102538.